Strong Day 3 Subscription for Symbiotec Pharmalab and Skyways Air Services IPOs

Symbiotec Pharmalab and Skyways Air Services have both attracted strong investor interest on the third day of their initial public offerings, with subscriptions exceeding two times and nearly three times respectively. High grey market premiums signal expectations of solid listing gains for both companies.